Cormark Issues Negative Estimate for OTCMKTS:GTBIF Earnings

Green Thumb Industries Inc. (OTCMKTS:GTBIF) – Equities research analysts at Cormark decreased their FY2025 earnings per share (EPS) estimates for Green Thumb Industries in a research report issued to clients and investors on Friday, February 28th. Cormark analyst J. Pytlak now forecasts that the company will post earnings per share of $0.36 for the year, down from their previous forecast of $0.40. The consensus estimate for Green Thumb Industries’ current full-year earnings is $0.32 per share.

Separately, Roth Capital upgraded Green Thumb Industries to a “strong-buy” rating in a research note on Sunday, November 10th. Two equities research analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company. According to MarketBeat, Green Thumb Industries currently has a consensus rating of “Strong Buy” and an average price target of $16.50.

Green Thumb Industries Price Performance

Shares of Green Thumb Industries stock opened at $6.69 on Monday. The company has a market capitalization of $1.42 billion, a PE ratio of 27.88 and a beta of 1.31. Green Thumb Industries has a 1-year low of $6.57 and a 1-year high of $16.33. The business has a 50-day moving average of $7.33 and a 200-day moving average of $8.91.

Green Thumb Industries (OTCMKTS:GTBIF) last announced its earnings results on Wednesday, February 26th. The company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.02). The business had revenue of $294.32 million for the quarter, compared to analyst estimates of $289.66 million. Green Thumb Industries had a net margin of 5.38% and a return on equity of 3.39%.

About Green Thumb Industries

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.